Australia markets closed

Biodexa Pharmaceuticals Plc (5MP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.9100-0.1000 (-9.01%)
As of 08:03AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
381
381
699
578
343
Cost of revenue
4,067
4,067
5,111
4,654
6,068
Gross profit
-3,686
-3,686
-4,412
-4,076
-5,725
Operating expenses
Selling general and administrative
4,342
4,342
4,542
2,946
4,958
Total operating expenses
4,328
4,328
4,520
2,922
4,946
Operating income or loss
-8,014
-8,014
-8,932
-6,998
-10,671
Interest expense
41
41
53
44
34
Total other income/expenses net
487
487
468
936
-12,766
Income before tax
-7,485
-7,485
-8,488
-6,106
-23,470
Income tax expense
-406
-406
-832
-646
-1,281
Income from continuing operations
-7,079
-7,079
-7,656
-5,460
-22,189
Net income
-7,079
-7,079
-7,656
-5,460
-22,189
Net income available to common shareholders
-7,079
-7,079
-7,656
-5,460
-22,189
Basic EPS
-692.00
-
-620.00
-544.00
-4.14k
Diluted EPS
-692.00
-
-620.00
-544.00
-4.14k
Basic average shares
12.399
-
12.354
10.068
5.355
Diluted average shares
12.399
-
12.354
10.068
5.355